Expression profiling for bladder cancer: Strategies to uncover prognostic factors

Georg Bartsch, Anirban P. Mitra, Richard J. Cote

Research output: Contribution to journalReview articlepeer-review

21 Scopus citations


Despite being a common cancer worldwide, management of transitional cell carcinoma of the bladder currently relies primarily on clinical staging and histopathologic parameters. Assaying alterations in molecular pathways can contribute valuable information that can accurately predict outcome and chemotherapeutic response in individual patients with bladder cancer. Medium-to high-throughput gene-expression profiling technologies are now allowing multiplexed assessment of alterations responsible for the genesis and progression of bladder tumors. These investigations employ global or pathway-based approaches to define molecular signatures that can predict prognosis independent of traditional clinical performance metrics. Prognostic panels generated using these strategies can also elucidate the biology of tumor progression and identify potential therapeutic targets.

Original languageEnglish
Pages (from-to)1945-1954
Number of pages10
JournalExpert Review of Anticancer Therapy
Issue number12
StatePublished - Dec 2010


  • gene-expression profiling
  • global approach
  • microarray
  • multimarker analysis
  • pathway-specific approach
  • urothelial carcinoma


Dive into the research topics of 'Expression profiling for bladder cancer: Strategies to uncover prognostic factors'. Together they form a unique fingerprint.

Cite this